Potency and In Vivo Recovery of High Purity Factor VIII Concentrates

Please copy the URL and add it into your RSS Feed Reader.

Thromb Haemost 1994; 72(01): 160-161
DOI: 10.1055/s-0038-1648830

Letter to the Editor

Schattauer GmbH Stuttgart

Authors

Marianne Mikaelsson

¹Research and Development, University Hospital, Malmö, Sweden
Ulla Oswaldsson

¹Research and Development, University Hospital, Malmö, Sweden
Inga Marie Nilsson

²Plasma Products, Kabi Pharmacia AB, and Department for Coagulation Disorders, University Hospital, Malmö, Sweden

Received 24 June 1992

Accepted after revision 21 March 1994

Publication Date:
12 July 2018 (online)

References
1 Barrowcliffe TW, Watton J, Harman A, Tubbs JE, Kemball-Cook G. Potency of high purity factor VIII concentrates. Lancet 1990; ii: 124

Reference Link Ris
PubMed Search in Google Scholar
2 Dawson NJ, Kemball-Cook G, Barrowcliffe TW. Assay discrepancies with highly purified factor VIII concentrates. Haemostasis 1989; 19: 131-137

Reference Link Ris
PubMed Search in Google Scholar
3 Nilsson IM, Bemtorp E. Clinical efficacy of clotting factor concentrates: survival, recovery and hemostatic capacity. In: Coagulation and Blood Transfusion Smit Sibinga CTh, Das PC, Mannucci PM. (eds) Dordrecht, The Netherlands: Kluwer Academic Publishers; 1991. pp 193-206

Reference Link Ris
4 Morfini M, Lee M, Messori A. The design and analysis of half-life and recovery studies for factor VIII and factor IX. Thromb Haemost 1991; 66: 384-386

Reference Link Ris
Thieme Connect PubMed Search in Google Scholar